The FDA granted marketing authorization for the ProSense Cryoablation System for small, early-stage breast cancer in older ...

The cryoablation treatment is indicated for women aged 70 and above with early-stage, low-risk breast tumours.

More men are now living long enough to develop osteoporosis. But few are aware of the risk, and fewer still are screened and ...

Whilst 'longevity' has become somewhat of a buzzword in recent months, experts say we shouldn't just be focusing on ...

IceCure receives US FDA marketing authorization for ProSense cryoablation to treat low-risk breast cancer in women aged 70 and above: Caesarea, Israel Monday, October 6, 2025, 11: ...

The removal of a diseased parathyroid gland could reduce the risk of people developing diabetes by 30%, according to new findings. Primary hyperparathyroidism (PHPT) is the third most common endocrine ...

Discover the symptoms of chronic pancreatitis and learn effective management strategies for a healthier life. Read the ...

The market is in a phase of rapid advancement, driven by expanding indications and new technology. A strong focus on ...

ProSense ® cryoablation offers the choice of  a minimally invasive outpatient procedure that destroys tumors by freezing ...

Vitamin D significantly affects IBD by influencing severity, inflammation, and patient outcomes. Optimizing vitamin D levels ...

Bremelanotide, also known by its research designation PT-141, is a synthetic cyclic heptapeptide derived from the ...